At 6.7% CAGR, Global Gastric Electrical Stimulators Market to Surpass US$ 220.2 million By 2025, Forecast Report By Zion Market Research.

Gastric electrical stimulators are small battery operated neurostimulators that are implanted beneath the skin in the lower abdomen area to treat gastroparesis. It consists of insulated wires that are implanted in the muscle wall of the stomach and then connected to the neurostimulator which delivers mild electric pulses that stimulate the lower stomach and control symptoms like vomiting and chronic nausea in patients aged from 18 to 70 years. Currently, there is only one type of therapy approved by the U.S. FDA in the market for the treatment of gastroparesis known as the Enterra therapy system which is based on the humanitarian device exemption.

Read More